(4s,5r) -3-tert-butoxycarbony-2- (4-anisyl) -4- phenyl-5- oxazolidine carboxylic acid na-eji dị ka etiti nke Docetaxel.
Docetaxel dabara adaba maka ọgwụgwọ ọrịa kansa ara dị elu nke mpaghara ma ọ bụ metastatic.Docetaxel kwesịrị ekwesị maka ọgwụgwọ ọrịa cancer akpa ume na-abụghị nke obere cell ma ọ bụ metastatic, ọbụlagodi na ọdịda nke cisplatin dabeere na chemotherapy.